Bambusa Therapeutics (BBTX) closed at $16.75 on November 12, 2026, down 2.4% from the previous close, on volume of 93,209 shares (30-day average 477,296).
Data as of November 12, 2026.
No headlines found.
No press releases found.
No news found.
Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.
Bambusa Therapeutics trades on the NASDAQ stock market under the symbol BBTX.
As of November 12, 2026, BBTX stock price declined to $16.75 with 93,209 million shares trading.
BBTX has a market cap of $853.29 million. This is considered a Small Cap stock.
BBTX support price is $16.13 and resistance is $18.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBTX shares will trade within this expected range on the day.
